DANIELI, Maria Giovanna
 Distribuzione geografica
Continente #
NA - Nord America 6.885
EU - Europa 3.279
AS - Asia 2.898
SA - Sud America 700
AF - Africa 143
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.916
Nazione #
US - Stati Uniti d'America 6.663
SG - Singapore 928
IT - Italia 739
VN - Vietnam 697
BR - Brasile 543
RU - Federazione Russa 519
CN - Cina 456
UA - Ucraina 387
DE - Germania 297
IE - Irlanda 240
SE - Svezia 226
HK - Hong Kong 216
FR - Francia 204
GB - Regno Unito 170
FI - Finlandia 168
DK - Danimarca 138
CA - Canada 132
TR - Turchia 108
BD - Bangladesh 105
IN - India 85
KR - Corea 75
MX - Messico 64
NL - Olanda 63
AR - Argentina 52
MA - Marocco 46
CI - Costa d'Avorio 41
IQ - Iraq 38
PL - Polonia 28
PK - Pakistan 27
EC - Ecuador 24
ZA - Sudafrica 24
ID - Indonesia 22
JP - Giappone 20
VE - Venezuela 20
AT - Austria 19
CO - Colombia 19
PH - Filippine 19
BE - Belgio 17
ES - Italia 16
CL - Cile 15
UZ - Uzbekistan 14
LT - Lituania 11
SA - Arabia Saudita 11
TN - Tunisia 11
PY - Paraguay 10
TW - Taiwan 8
AU - Australia 7
IL - Israele 7
JO - Giordania 7
PE - Perù 7
IR - Iran 6
RS - Serbia 6
TH - Thailandia 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
CH - Svizzera 5
HN - Honduras 5
KZ - Kazakistan 5
MY - Malesia 5
UY - Uruguay 5
AZ - Azerbaigian 4
DZ - Algeria 4
NP - Nepal 4
RO - Romania 4
CR - Costa Rica 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
EU - Europa 3
GR - Grecia 3
JM - Giamaica 3
MD - Moldavia 3
NI - Nicaragua 3
OM - Oman 3
PS - Palestinian Territory 3
UG - Uganda 3
BH - Bahrain 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
EG - Egitto 2
HU - Ungheria 2
KE - Kenya 2
KW - Kuwait 2
LB - Libano 2
NG - Nigeria 2
PR - Porto Rico 2
QA - Qatar 2
SR - Suriname 2
SV - El Salvador 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BY - Bielorussia 1
BZ - Belize 1
DM - Dominica 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 13.903
Città #
Ashburn 1.218
Dallas 1.029
Singapore 569
Jacksonville 391
Chandler 388
San Jose 344
Fairfield 257
Dublin 233
Boardman 229
Ho Chi Minh City 223
Hong Kong 208
New York 183
Hanoi 167
Wilmington 150
Woodbridge 144
The Dalles 133
Los Angeles 123
Beijing 119
Lauterbourg 109
Moscow 109
Munich 102
Seattle 102
Houston 101
Ann Arbor 97
Helsinki 90
Lawrence 87
Princeton 87
Des Moines 85
San Mateo 82
Milan 71
Cambridge 66
Montréal 62
Centro 59
Hefei 53
São Paulo 50
Mcallen 49
Ancona 45
Orem 42
Abidjan 41
San Diego 41
Montreal 40
Council Bluffs 39
Buffalo 38
Santa Clara 34
Chicago 33
Da Nang 32
Mexico City 30
Turin 29
Warsaw 26
Chennai 24
Washington 24
Haiphong 22
Amsterdam 19
Shanghai 18
Frankfurt am Main 17
London 17
Pune 17
Brussels 16
Florence 16
Guangzhou 16
Redmond 16
Rome 16
Tokyo 16
Baghdad 15
Stockholm 15
Atlanta 14
Hải Dương 14
Johannesburg 14
Rio de Janeiro 14
Tashkent 14
Wuhan 14
Manchester 13
Nuremberg 13
Boston 12
Brasília 12
Brooklyn 12
Denver 12
Miano 12
Phoenix 12
Poplar 12
Saint Petersburg 12
Thái Bình 12
Castelfidardo 11
Dhaka 11
Salvador 11
Ankara 10
Bologna 10
Columbus 10
Curitiba 10
Lahore 10
Norwalk 10
Salt Lake City 10
Turku 10
Chiaravalle 9
Belo Horizonte 8
Buenos Aires 8
Charlotte 8
Guayaquil 8
Istanbul 8
Kilburn 8
Totale 8.711
Nome #
Prurigo nodularis as the first manifestation of a common variable immunodeficiency 344
Insights from comparison of serum IgG4 between T2-eosinophilic asthma and eosinophilic granulomatosis with polyangiitis/idiopathic hypereosinophilic syndrome 249
Expanding the mosaic functions of intravenous immunoglobulin 238
Use of nailfold capillaroscopy for the early diagnosis of systemic sclerosis in patients with primary biliary cholangitis 216
Colonna vertebrale. Midollo spinale. Imaging 205
7th International Immunoglobulin Conference: Immunomodulation. 203
La scelta della maternità. Una guida alla decisione per le donne con LES 182
Clinical features and follow-up in patients with 22q11.2 deletion syndrome. 181
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITHOUT OVERT NEUROPSYCHIATRIC MANIFESTATIONS 176
ANCA-negative EGPA: only eosinophils without vasculitis? Insights from anti-T2 biologics 172
A Case of CVID-Associated Inflammatory Bowel Disease with CTLA-4 Mutation Treated with Abatacept 170
IMMUNOSUPPRESSIVE THERAPY IN LUPUS NEPHRITIS: A RANDOMISED TRIAL OF LOW DOSE VERSUS HIGH DOSE INTRAVENOUS CYCLOPHOSPHAMIDE. THE EUROLUPUS NEPHRITIS TRIAL. 169
Global longitudinal strain measured by speckle tracking identifies subclinical heart involvement in patients with systemic sclerosis 168
Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: Results from the MAINTAIN Nephritis Trial 155
Cardiac involvement in polymyositis and dermatomyositis 154
Overexpression of the cytokine BAFF and autoimmunity risk 154
Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia. 151
Incidence of malignancy in patients with common variable immunodeficiency according to therapeutic delay: an Italian retrospective, monocentric cohort study 151
Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases. 150
The ten-year follow-up data of the Euro-lupus Nephritis Trial comparing low-dose versus high-dose intravenous cyclophosphamide. 146
The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999–2019) 146
6th International Immunoglobulin Symposium: poster presentations. 145
A proteinuria cut-off level of 0.7 g /day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: Data from the MAINTAIN Nephritis Trial 145
Intravenous immunoglobulin as a therapy for autoimmune conditions 143
Antibodies to mycobacterial 65 kDa heat shock protein in systemic sclerosis (scleroderma). 141
Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome. 141
Autoimmune thyroid diseases in patients with undifferentiated connective tissue disease. 140
Subcutaneous IgG in the Myositis Spectrum Disorders 138
Subcutaneous immunoglobulin in inflammatory myopathies: efficacy in different organ systems 138
Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD. 137
Juvenile rheumatoid arthritis patients manifest immune reactivity to the mycobacterial 65-kDa heat shock protein, to its 180-188 peptide, and to a partially homologous peptide of the proteoglycan link protein. 137
Serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and systemic idiopathic vasculitis. 137
Immunohistochemical localization of intracellular and extracellular associated TGF beta in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon. 135
Association tests with systemic lupus erythematosus (SLE) of IL10 arkers indicate a direct involvement of a CA repeat in the 5' regulatory region 133
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies 133
Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study 133
The EuroMyositis registry: An international collaborative tool to facilitate myositis research 133
A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases 132
Alarmins in autoimmune diseases 126
Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application. 125
Dr. Guerra, et al reply 125
[Therapy of refractory rheumatoid arthritis. Cyclosporin and methotrexate combination] 124
Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus. 124
Autoimmunità, Gravidanza, Contraccezione, Terapia ormonale 124
la terapia con immunoglobuline endovena nel trattamento delle malattie autoimmuni 122
Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis. 121
Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. 121
Facilitated Subcutaneous Immunoglobulin (fSCIg) in Autoimmune Cytopenias Associated with Common Variable Immunodeficiency 120
Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: A systematic review and meta-analysis 119
Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients 119
Bullous SLE: response to methotrexate and relationship with disease activity 117
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. 115
Potential Anti-Tumor Activity of Intravenous and Subcutaneous Immunoglobulin 115
Common Variable Immunodeficiency in Elderly Patients: A Long-Term Clinical Experience 115
Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin therapy in complicated primary antibody deficiencies 113
Autoimmunità Gravidanza Contraccezione Terapia Ormonale 112
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. 110
Management of a pregnant woman with common variable immunodeficiency and previous reactions to intravenous IgG administration 108
A machine learning analysis to evaluate the outcome measures in inflammatory myopathies 107
Rare variants in the TREX1 gene and susceptibility to autoimmune diseases. 106
Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial 106
Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study. 105
Clinical Associations of Biallelic and Monoallelic TNFRSF13B Variants in Italian Primary Antibody Deficiency Syndromes 105
Open-label study on treatment with 20 % subcutaneous IgG administration in polymyositis and dermatomyositis. 104
Intravenous Immunoglobulin and Mycophenolate Mofetil for Long-Standing Sensory Neuronopathy in Sjögren's Syndrome 104
Ultrasonographic contrast-enhanced study of sicca syndrome 102
Platelet-activating factor acetylhydrolase: A biomarker in Hymenoptera venom allergy? 102
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project 101
La terapia immunosoppressiva nelle miositi refratttarie 100
Risk factors for Sjögren's syndrome: a case-control study. 100
Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study. 98
Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life 97
Low-dose intravenous immunoglobulin (IVIg) in different immune-mediated conditions 96
Sinchronised therapy and high-dose cyclophosphamide in proliferative lupus nephritis. 96
Systemic lupus in Europe at the change of the millennium: lessons from the "Euro-lupus Project" 96
High-dose Facilitated subcutaneous Immunoglobulin in a Patient with refractory Polymyositis and severe Interstitial Lung disease 96
Subcutaneous IgG in immune-mediate diseases: proposed mechanisms of action and literature review. 95
Subcutaneous immunoglobulins in ocular myositis. 95
Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease 94
Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. 93
Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations 93
Exposome: Epigenetics and autoimmune diseases 92
Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination 92
Hydroxychloroquine-induced seizure in a patient with systemic lupus erythematosus. 91
The European Society for Immunodeficiencies (ESID) registry 2014 90
Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis. 89
Oxidative stress, mitochondrial dysfunction, and respiratory chain enzyme defects in inflammatory myopathies 88
Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome: its relationship to different demographic, clinical and serological features of the disorder. 88
Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis 88
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey 87
The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet) 87
Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus 86
Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagnaet al 85
Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome. 84
Lessons from the "Euro-Lupus Cohort". 84
Preliminary report on the use of subcutaneous immunoglobulin in severe inflammatory myopathies 84
Hypogammaglobulinemia in patients affected by limited cutaneous systemic sclerosis: Case series and review of the literature 83
Polyautoimmunity Reflecting Immune Dysregulation in Common Variable Immunodeficiency 83
Immunoglobulin Treatment inPolymyositis and Dermatomyositis 83
Recurrent myelitis in common variable immunodeficiency successfully managed with high-dose subcutaneous immunoglobulin. 83
Totale 12.534
Categoria #
all - tutte 60.337
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.337


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202167 0 0 0 0 0 0 0 0 0 0 0 67
2021/2022674 29 176 15 34 3 35 45 58 46 44 74 115
2022/20231.263 104 115 99 104 104 169 5 82 324 13 99 45
2023/2024915 158 40 56 123 143 188 18 34 10 32 19 94
2024/20251.759 134 170 75 31 66 94 178 91 326 158 180 256
2025/20266.932 306 878 629 654 695 448 1.140 641 536 606 191 208
Totale 14.149